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Introduction: The production of antimicrobial peptides by airway epithelial cells is an important component of
the innate immune response to pulmonary infection and inflammation. Hepcidin is a β-defensin-like antimicrobial
peptide and acts as a principal iron regulatory hormone. Hepcidin is mostly produced by hepatocytes, but is also
expressed by other cells, such as airway epithelial cells. However, nothing is known about its function in lung
infections and inflammatory diseases. We therefore sought to investigate the role of airway epithelial cell-derived
hepcidin in sepsis-induced acute lung injury.
Methods: Acute lung injury was induced by polymicrobial sepsis via cecal ligation and puncture (CLP) surgery.
Adenovirus-mediated short hairpin RNA specific for the mouse hepcidin gene hepc1 and control adenovirus were
intratracheally injected into mice. The adenovirus-mediated knockdown of hepcidin in airway epithelial cells was
evaluated in vivo. Lung injury and the seven-day survival rate were assessed. The levels of hepcidin-related iron
export protein ferroportin were measured, and the iron content and function of alveolar macrophages were
evaluated.
Results: The hepcidin level in airway epithelial cells was upregulated during polymicrobial sepsis. The knockdown
of airway epithelial cell-derived hepcidin aggravated the polymicrobial sepsis-induced lung injury and pulmonary
bacterial infection and increased mortality (53.33% in Ad-shHepc1-treated mice versus 12.5% in Ad-shNeg-treated
mice, P <0.05). The knockdown of hepcidin in airway epithelial cells also led to reduced ferroportin degradation
and a low intracellular iron content in alveolar macrophages. Moreover, alveolar macrophages form the airway
epithelial cell-derived hepcidin knockdown mice showed impaired phagocytic ability than those from the control
mice.
Conclusions: Airway epithelial cell-derived hepcidin plays an important role in CLP-induced acute lung injury. The
severe lung injury in the airway epithelial cell-derived hepcidin knockdown mice is at least partially related to the
altered intracellular iron level and function of alveolar macrophages.Introduction
Acute lung injury (ALI) and its severe form, acute respi-
ratory distress syndrome (ARDS), are common clinical
disorders and present substantial health problems world-
wide [1-3]. The incidence of ALI has been reported to be
190,000 cases per year in the United States, and sepsis is
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ces in supportive care, the mortality rate for patients with
ALI/ARDS has decreased over time but still remains
high [5,6]. Therefore, elucidating the pathogenesis of
ALI/ARDS is necessary and may help with the develop-
ment of novel therapeutic targets for ALI/ARDS.
The lung is exposed to a large number of potentially
pathogenic microorganisms that are inhaled. To protect
this vital organ against infection and inflammation, many
defense mechanisms have been evolved in the lung to pre-
vent the development of pulmonary infections. The secre-
tion of endogenous cationic antimicrobial peptides by
epithelial cells onto the airway surface represents antd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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[7-9]. Recent studies have demonstrated the importance
of these antimicrobial peptides, such as defensins and
cathelicidin, in the pulmonary immune system and in
pulmonary diseases [10-12].
Hepcidin is a β-defensin-like antimicrobial peptide that
is mainly produced by the liver. Hepcidin not only
shows antimicrobial activity against Gram-positive bac-
teria, Gram-negative bacteria and yeasts, but also functions
as a principal iron regulatory hormone [13-15]. Hepcidin
binds to the iron export protein ferroportin and induces its
internalization and degradation, which leads to decreased
cellular iron export and increased intracellular iron reten-
tion [16,17]. Because iron is an essential nutrient for all
organisms, hepcidin also restricts the iron available to
invading microbes, thereby enhancing the host defense
against pathogens [17-19]. Furthermore, hepcidin can
modulate the lipopolysaccharide (LPS)-induced acute
inflammatory response via the suppression of cytokine
expression [20,21]. The multiple functions of hepcidin
suggest its importance in the host immune response to
infection and inflammation. Recent studies have reported
that in addition to being produced mainly by hepatocytes,
hepcidin is also expressed by other cells, such as airway
epithelial cells (AECs) [22]. However, the role of AEC-
derived hepcidin in pulmonary immune defense against
infection and inflammation remains unknown.
In the present study, we generated a mouse model of
AEC-derived hepcidin knockdown and investigated the
impact of interfering with AEC-derived hepcidin on the
pathophysiology of sepsis-induced ALI. We also explored
the possible mechanisms involved.
Materials and methods
Adenovirus-mediated short hairpin RNA (shRNA)
As the mouse hepcidin gene hepc1 performs similar bio-
logical actions as human hepcidin [23,24], we investigated
hepc1 in the present study. Small interfering RNA specific
to the mouse hepc1 (ACAGAUGAGACAGACUACAdT
dT) was described previously [25], and we used this
template to design the corresponding shRNA (ACCGAC
AGATGAGACAGACTACATTCATGAGATGTAGTCT
GTCTCATCTGTCTTTTT) with minor modifications
(Invitrogen, Shanghai, China). An adenovirus that ex-
presses the hepc1 shRNA or a nonspecific control oligo-
nucleotide (GCCTAAGGTTAAGTCGCCCTCGCGAAC
GAAGGCGAGGGCGACTTAACCTTAGGTT) was pre-
pared. Briefly, the double-strand shRNA oligo was cloned
into pENTR/U6 vector using the BLOCK-iT U6 RNAi
Entry Vector Kit (Life Technologies, Grand Island,
NY, USA). The expression clone was then generated
by recombination of pENTR/U6 entry construct and
pAd/BLOCK-IT-DEST vector using BLOCK-iT Adenoviral
RNAi Expression System (Life Technologies) according tothe manufacturer’s instructions. After digested by endo-
nuclease PacI (New England Biolabs, Ipswich, MA, USA),
the recombinant adenoviral plasmid was transfected into
293A cells. The harvested adenovirus was concentrated
and purified by CsCl gradient centrifugation. Viral titer
was determined using Adeno-X Rapid Titer Kit (Clontech,
Mountain View, CA, USA). The recombinant virus and
control virus were named Ad-shHepc1 and Ad-shNeg,
respectively.
Animals and adenovirus treatment
C57BL/6 male mice aged six to eight weeks (Zhejiang
Chinese Medicine University, Hangzhou, China) were
used in this study. The mice were housed under stand-
ard care conditions. The animal studies were approved
by the Animal Care and Use Committee of Zhejiang
University (Reference No. 2014133; Hangzhou, Zhejiang
Province, China) and handling of the animals were in
accord with National Institutes of Health guidelines for
ethical animal treatment.
To generate a mouse model of AEC-derived hepcidin
knockdown, Ad-shHepc1 or Ad-shNeg (approximately
2.2 × 1011 viral particles) was intratracheally injected into
the mice after anesthesia with chloral hydrate (400 mg/kg,
intraperitoneally (i.p.)). To improve the knockdown
efficiency, a second administration of the adenovirus
was performed 72 hours later. Twelve days after the first
injection, the mice were ready used in the experiments.
ALI model
ALI was induced by polymicrobial sepsis with cecal
ligation and puncture (CLP) surgery as described previ-
ously [26]. Briefly, after the abdominal wall was prepared
with a 10% povidone-iodine solution, a 1-cm midline
abdominal incision was made. The cecum was then ex-
posed, isolated, and ligated with a 4-0 silk ligature just dis-
tal to the ileocecal valve to avoid intestinal obstruction.
The puncture was performed twice with a 22-gauge nee-
dle. Then, the cecum was repositioned, and the incision
was closed with a 4-0 sterile suture. Sham-operated mice
were underwent the same procedure but without ligation
and needle perforation of the cecum. At the end of the
operation, the mice were resuscitated immediately by the
subcutaneous administration of saline (1 ml/mouse) and
allowed free access to food and water after awakening. In
the experiment to evaluate the survival rate, the mice were
monitored for survival every six to twelve hours until
seven days post-CLP.
Bronchoalveolar lavage fluid (BALF) analysis
Twenty-four hours after CLP, the mice were sacrificed via
cervical dislocation. The chest cavity was opened via a
midline incision. To perform the bronchoalveolar lavage,
the lung was lavaged with 0.5 ml of chilled phosphate-
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the total lavage volume was recovered. A 0.5-ml aliquot of
BALF was used for the total cell counts and bacteriologic
culture. The remaining BALF was centrifuged at 1000 g
for five minutes, and the cell-free supernatant was stored
at -80°C for further analysis.
Cell count
The total cell count in the BALF was determined using a
hemocytometer.
Bacteriologic culture
The BALF was serially diluted in phosphate-buffered
saline and inoculated on Luria Broth agar plates. After
incubation at 37°C for 16 hours, visible colonies were
counted and calculated as colony-forming units/ml of
BALF.
Protein concentration assay
The total protein in the cell-free supernatant of the
BALF was determined by using the BCA Protein Assay
kit (Pierce, Rockford, IL, USA).
Cytokine measurement
The interleukin (IL)-6 level in the BALF was determined
using an enzyme-linked immunosorbent assay kit accor-
ding to the manufacturer’s instructions (Abcam, San
Francisco, CA, USA).
Lung wet/dry weight ratio
In separate groups the lung was excised, weighed, and
then placed in an oven at 60°C for 72 hours to achieve the
dry weight. The ratio of lung wet weight to dry weight was
then calculated.
Lung histology
The lung tissues from the mice were fixed in buffered 4%
paraformaldehyde solution (pH = 7.4) for 24 hours, em-
bedded in paraffin, and sectioned at a thickness of 4 μm.
The histological examination was conducted in a blinded
fashion after staining with hematoxylin and eosin.
Quantitative polymerase chain reaction (qPCR)
For RNA extraction, alveolar macrophages were isolated
by adhering bronchoalveolar lavage cells to plastic for
one hour at 37°C in 5% CO2 [27]. Total RNA of the lung
and liver tissues as well as the alveolar macrophages was
extracted using the TRIzol™ Reagent. Reverse transcrip-
tion was performed using 1 μg of total RNA with the
Reverse Transcription System (Promega, Madison, WI,
USA). The transcriptional level of hepcidin was quantified
by real-time PCR using a standard SYBR™ Green PCR
protocol on a CFX96 real-time PCR detection system
(Bio-Rad Laboratories Inc., Hercules, CA, USA). Thehousekeeping gene β-actin served as an internal control,
and the relative expression level of hepcidin was calcu-
lated using the 2−ΔΔCT method.
Immunohistochemistry
Immunohistochemical staining was performed following
standard procedures. The formalin-fixed paraffin-embed-
ded tissues were sliced into 4-μm-thick sections, deparaffi-
nized, and rehydrated. For the hepcidin measurement in
the alveolar macrophages, the cells were isolated by adher-
ing bronchoalveolar lavage cells to coverslips at 37°C in
5% CO2. Then, the cells were fixed with 95% ethanol for
15 minutes. Antigen retrieval was performed in 10 mmol/
L citric acid buffer (pH 6.0) for 10 minutes using a 750-W
microwave. Endogenous peroxidase activity was blocked
with 3% hydrogen peroxide in methanol for 15 minutes.
After incubation with rabbit anti-mouse hepcidin antibody
(1:400 dilution; Abcam) overnight at 4°C, the sections
were washed in phosphate-buffered saline and incubated
with a polymer horseradish peroxidase-conjugated secon-
dary antibody (ZSGB-Bio, Beijing, China) for one hour.
The sections were further incubated with Dako Liquid
DAB Large-Volume Substrate-Chromogen System (DAKO,
Glostrup, Denmark) and counterstained with hematoxylin.
Negative controls were included in all assays by replacing
the rabbit anti-mouse hepcidin antibody with nonimmune
rabbit antiserum. The immunostaining was evaluated using
an Olympus BX-50 light microscope (Olympus, Tokyo,
Japan). The stain density was analyzed using the Image
Pro-Plus 6.0 analysis system (Media Cybernetics Inc., Silver
Spring, MD, USA), and the level of hepcidin was measured
as the integral optical density.
Western blot analysis
The protein concentrations in the lung homogenate or
lysate of alveolar macrophages were detected using a
BCA Protein Assay Kit (Pierce). The proteins (20 μg)
were denatured by heating at 70°C for 10 minutes in 4 ×
nuPAGE LDs sample buffer (Life Technologies) and
separated by nuPAGE Bis-Tris gel electrophoresis
(Life Technologies). Then, the proteins were blotted onto
polyvinylidene fluoride membrane (Millipore, Billerica,
MA, USA). The membranes were blocked with 5% nonfat
milk in Tris-buffered saline with 0.05% Tween-20 and
incubated overnight with goat anti-ferroportin antibody
(Santa Cruz Biotechnology, Dallas, TX, USA). The mem-
branes were then washed with Tris-buffered saline with
0.05% Tween-20 three times for five to ten minutes each.
After incubation with the related horseradish peroxidase-
conjugated secondary antibody (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA, USA), the membranes
were visualized with the SuperSignal West Pico Chemilu-
minescent Substrate (Pierce). The signals were quantified
using the Image J software by Wayne Rasband (National
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Actin served as a protein control.
Iron determination
The iron content in alveolar macrophages and spleen
was determined by Prussian blue staining using a com-
mercially available kit according to the manufacturer’s
instructions (Shanghai Yuanye Bio-Technology Co.,
Shanghai, China). The stain density in the spleen was
analyzed using the Image Pro-Plus 6.0 analysis system as
described above. For the iron measurement in the alveolar
macrophages, the cells were isolated by adhering broncho-
alveolar lavage cells to coverslips at 37°C in 5% CO2. Then,
the cells were fixed with 95% ethanol for 15 minutes. The
cells were considered positive with the presence of blue-
colored granules within intact alveolar macrophages under
a microscope. At least 200 random macrophages were
counted, and the results are presented in terms of the
percentage of positive cells.
The serum iron concentration was measured using
atomic absorption spectroscopy [28].
Phagocytosis assay
To investigate the phagocytosis function of alveolar macro-
phage, alveolar macrophages were isolated as described
above. The cells were then incubated with fluorescent
Escherichia coli (Life Technologies) for two hours. Fluo-
rescence from the extracellular bacteria was quenched
with 0.4% trypan blue. After three washes with phosphate-
buffered saline, the fluorescence was observed under a
fluorescence microscope (Olympus). The phagocytic index
was quantified as number of fluorescent E.coli internalized
by one macrophage cell counted in 10 random fields.
Statistical analysis
The data are expressed as the mean ± standard deviation
(SD) or median with range where applicable. The differ-
ences between the two groups were analyzed by the t test
or Mann-Whitney U test. The survival curves were ana-
lyzed by the Kaplan-Meier log-rank test. The statistical
analyses were performed using GraphPad Prism software
5.0 (GraphPad Software Inc., La Jolla, CA, USA) and SPSS
16.0 for Windows (SPSS Inc., Chicago, IL, USA). A two-
tailed P value of less than 0.05 was considered to be statis-
tically significant.
Results
Hepcidin expression is modulated in response to infec-
tious and inflammatory stimuli [14,17]. We first investi-
gated whether the hepcidin expression level in the lung
tissue changed during polymicrobial sepsis. Twenty-four
hours after CLP surgery, the hepcidin level was signifi-
cantly increased in the lung tissue, especially in the
AECs (Figure 1). This finding indicates that hepcidinderived from AECs may play an important role in
sepsis-induced ALI.
To confirm the role of hepcidin in ALI, Ad-shHepc1
or Ad-shNeg was administered to the mice via intratra-
cheal instillation. Twelve days after administration of the
adenovirus-mediated shRNA, the mice were subjected to
an ALI model, and the hepcidin level in lung and liver
were assessed at 24 hours after induction of ALI. As
shown in Figure 2A and 2B, both the mRNA and protein
levels of hepcidin in AECs was significantly reduced,
whereas the hepcidin expression in alveolar macrophages
(Figure 2C and 2D) and hepatocytes (Figure 2E and 2F)
was not affected. These results demonstrated that in
the current study the intratracheal administration of
Ad-shHepc1 only silenced the hepcidin gene transcription
in AECs, which was in accordance with previous studies
that adenovirus-mediated intratracheal gene delivery
specifically inhibited targeted gene expression in lung
epithelial cells but not in alveolar macrophages and other
organs [29,30].
The lung injury was evaluated both in wild-type mice
and adenovirus-treated mice at 24 hours after challenge
with CLP or a sham operation. Histological characte-
ristics of lung injury, including diffuse alveolar damage,
infiltration of numerous leukocytes and interstitial edema,
were observed both in the wild-type mice and Ad-shNeg-
treated mice after CLP challenge. Knockdown of hepcidin
in AECs led to more severe lung damage in the Ad-
shHepc1-treated mice after CLP challenge (Figure 3A).
Lung wet/dry weight ratios from the experimental mice
further confirmed the histological findings (Figure 3B).
The BALF analysis showed that the hepcidin knockdown
mice had significantly higher cell counts and protein
concentrations (Figure 3C and 3D). Of note, pulmonary
bacterial colonization was much more severe in the
Ad-shHepc1-treated mice (Figure 3E). However, the
BALF IL-6 level in the hepcidin knockdown mice was
not significantly different from that in the control mice
(Figure 3F).
Moreover, the influence of disruption of the hepcidin
gene in AECs on the outcome of ALI was further studied.
CLP challenge caused a seven-day mortality of 18.75% in
the wild-type mice, comparable to a mortality of 12.5% in
the Ad-shNeg-treated mice. However, knockdown of hep-
cidin in AECs significantly increased the seven-day mor-
tality after CLP surgery (53.33% versus Ad-shNeg-treated
mice, P <0.05; Figure 3G).
Hepcidin regulates iron metabolism by binding to ferro-
portin and causing its internalization and degradation. We
therefore investigated the ferroportin levels in both whole
lung tissue and alveolar macrophages. As expected, the
ferroportin in the control mice was almost totally degra-
ded, whereas a higher ferroportin level was observed in
the hepcidin knockdown mice (Figure 4A and 4B).
Figure 1 The expression of hepcidin in airway epithelial cells (AEC) was upregulated after cecal ligation and puncture (CLP) surgery.
Hepcidin expression was examined by immunohistochemistry. A representative image is presented (magnification: ×400) and quantified data are
shown. n = 6 mice/group. *P <0.005.
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in AECs had an impact on local and systemic iron me-
tabolism. Of note, the knockdown of hepcidin in AECs
resulted in less iron retention in the alveolar macro-
phages (Figure 5A), whereas the iron contents in the
spleen macrophages and serum iron concentration be-
tween the two groups showed no significant differences
(Figure 5B and 5C).
Moreover, to link the intracellular iron content to the
function of alveolar macrophages, we assessed the phago-
cytosis of alveolar macrophages, and found that the alveo-
lar macrophages from Ad-shHepc1-treated mice showed
less phagocytic ability than those from the control animals
(Figure 5D).
Discussion
In the current study, we found that the pulmonary
hepcidin level was upregulated during polymicrobial sep-
sis. The knockdown of hepcidin in AECs aggravated the
polymicrobial sepsis-induced lung injury and pulmonary
bacterial infection and increased mortality. These patho-
physiologic changes are at least partially related to the
altered intracellular iron level and function of alveolar
macrophages in the hepcidin knockdown mice.
Hepcidin is produced predominantly by hepatocytes. Its
hepatic expression can be upregulated by iron overloadand inflammation and suppressed by hypoxia and anemia
[14,17]. A recent study reported that hepcidin is expressed
in AECs in response to interferon-γ [22]. In the current
study, an increased hepcidin level in AECs was observed
during polymicrobial sepsis. Because the lung is the first
vital organ that is adversely affected at the onset of sepsis
[31], the elevated expression of hepcidin may protect the
mice against lung injury. To support this hypothesis,
knockdown of hepcidin in AECs exacerbated sepsis-
induced lung injury (Figure 3). Considering that disrup-
tion of hepcidin has a deleterious effect, a low severity of
CLP model was used in the current study. Since the
underlying pathophysiology of sepsis is based on the se-
verity grade of the CLP model, the increase in lung injury
parameter such as wet/dry weight ratio was minuscule but
significantly different.
Hepcidin is a master regulator of iron metabolism via
its interaction with ferroportin. Hepcidin can trigger ferro-
portin polyubiquitination and induce ferroportin endo-
cytosis [32,33]. In the lung, AECs express high levels of
hepcidin and are the main source of local hepcidin pro-
duction. Alveolar macrophages express ferroportin and
are therefore target cells for hepcidin [22]. In the present
study, knockdown of hepcidin in AECs impacted its inter-
action with ferroportin, and prevented degradation of the
ferroportin protein in both alveolar macrophages and the
Figure 2 Evaluation of hepcidin silencing in vivo after cecal ligation and puncture (CLP) surgery. (A, B) Hepcidin expression in lungs was
detected by quantitative polymerase chain reaction and immunohistochemistry. A representative image is presented (magnification: ×400), and
quantified data are shown. n = 5 mice/group. *P <0.001. (C, D) Hepcidin mRNA and protein levels in alveolar macrophages were measured using
quantitative polymerase chain reaction and immunohistochemistry. A representative image is presented (magnification: ×400), and quantified
data are shown. n = 4 to 5 mice/group. (E, F) Hepcidin expression in livers was examined by quantitative polymerase chain reaction and
immunohistochemistry. A representative image is presented (magnification: ×400), and quantified data are shown. n = 5 mice/group.
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into the pulmonary microenvironment. The elevated iron
in the lung can be used not only for invading pathogen
growth and replication, resulting in more virulent and per-
sistent infections [18], but also to generate reactive oxygen
species, leading to cell damage and lung injury [34,35]. On
the other hand, a recent study showed that iron status
could impact cytoskeleton rearrangement, which is impor-
tant for the phagocytic process in macrophages [36]. In-
deed, the alveolar macrophages from Ad-shHepc1-treated
mice showed less phagocytosis ability than those from the
control animals. Since liver is the major source of systemic
hepcidin, in the current study liver hepcidin levels
were not affected and circulating iron concentrations
were comparable between the Ad-shNeg- and Ad-
shHepc1-treated mice. Therefore, the function of circulat-
ing leukocytes should not be influenced. Although the
inciting injury (CLP) is remote, when the bacteria circulat-
ing in the blood stream invaded the lung after CLP, thedecreased phagocytosis function of the alveolar macro-
phages from the Ad-shHepc1-treated mice could result in
bacterial accumulation in the lung. In addition, as hepci-
din exhibits broad spectrum antimicrobial properties [37],
the knockdown of hepcidin may contribute to more
severe pulmonary infections and lung injuries.
Using primary human AECs and alveolar macro-
phages, Frazier et al. reported that the treatment with
exogenous hepcidin did not affect ferroportin expression
in the AECs and did not alter iron accumulation in both
AECs and alveolar macrophages [22]. The contradictory
findings between the current study and Frazier’s study
may result from the difference between the in vivo
model and ex vivo model used and the nature of hepci-
din peptide. Moreover, limited by the sensitivity of the
Prussian blue staining method, the iron content in the
AECs was undetectable in this study. Because the role
of AECs in pulmonary iron metabolism is much less
than that of alveolar macrophages [22], the iron status in
Figure 3 The knockdown of hepcidin in airway epithelial cells worsened lung injury induced by cecal ligation and puncture (CLP)
surgery. (A) Hematoxylin and eosin stain of lung tissue sections. A representative image is presented (magnification: ×400). n = 5 to 6 mice/
group. (B) Lung wet/dry weight ratio. n = 5 to 6 mice/group. *P <0.05 versus Ad-shNeg-treated group. (C) Total cell counts in BALF. n = 5 to 6
mice/group. *P <0.05 versus Ad-shNeg-treated group. (D) BALF protein concentrations. n = 5 to 6 mice/group. *P <0.01 versus Ad-shNeg-treated
group. (E) Bacterial counts in BALF. n = 5 to 6 mice/group. *P <0.05 versus Ad-shNeg-treated group. (F) IL-6 concentrations in BALF. n = 5 to 6
mice/group. (G) Survival rate was monitored for seven days. n = 16 mice in the Ad-shNeg + CLP and CLP groups, and n = 15 mice in the other
groups. *P <0.05 versus Ad-shNeg-treated group.
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The production of cytokines and other inflammatory
mediators at the site of injury is a feature of the patho-
genesis of ALI, with IL-6 being one of the hallmarks
[38]. However, the BALF IL-6 level in the AEC-specific
hepcidin knockdown mice was not significantly different
from that in the control mice. Previous studies foundFigure 4 The knockdown of hepcidin in airway epithelial cells affecte
surgery. The ferroportin level was measured using Western blot analysis. E
ferroportin level in lung homogenates. *P <0.0001. (B) The ferroportin levethat low intracellular iron in macrophages could im-
pair the translation of specific inflammatory cytokine
transcripts, such as IL-6 [39,40]. Because alveolar macro-
phages are a major source of IL-6 production during
lung injury, the decreased iron content in alveolar
macrophages may compromise the local inflammatory
response in the AEC-specific hepcidin knockdown
mice.d pulmonary ferroportin after cecal ligation and puncture (CLP)
ach lane represents one mouse. Quantified data are shown. (A) The
l in alveolar macrophages (AM). *P <0.05.
Figure 5 The knockdown of hepcidin in airway epithelial cells altered intracellular iron metabolism and function of alveolar
macrophages after cecal ligation and puncture (CLP) surgery. (A, B) Iron levels in alveolar macrophages (A) and spleens (B) were evaluated
by Prussian blue stain. A representative image is presented (magnification: ×400), and quantified data are shown. n = 5 to 6 mice/group. (C)
Serum iron concentration was assayed using atomic absorption spectroscopy. n = 5 to 6 mice/group. *P <0.05. (D) Phagocytosis function of
alveolar macrophages was accessed. n = 6 mice/group. *P <0.005.
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The current study explored the role of AEC-derived
hepcidin in polymicrobial sepsis-induced ALI, which is
at least partially related to the altered intracellular iron
level and function of alveolar macrophages. These obser-
vations provide new insight into the pathogenesis of
ALI/ARDS and might have therapeutic implications for
ALI/ARDS.
Key messages
 Knockdown of airway epithelial cell-derived
hepcidin aggravated the polymicrobial
sepsis-induced lung injury and pulmonary
bacterial infection and increased
mortality.
 Knockdown of hepcidin in airway epithelial
cells led to reduced ferroportin degradation
in lung and a low intracellular iron content
in alveolar macrophages. These findings provide new insight into the
pathogenesis of ALI/ARDS and might have
therapeutic implications for ALI/ARDS.Abbreviations
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